Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder

Eculizumab demonstrated robust real-world effectiveness in reducing relapse rates and stabilizing disability, with an acceptable safety profile. Clinical outcomes may be influenced by attack phenotype, underscoring the importance of early intervention.

Authors

Institutions

Publication Details

Journal
Journal of Neurology
Published
2026-01-01
DOI
https://doi.org/10.1007/s00415-025-13608-w
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder

Belgin Koçer, Edgar Carnero-Contentti, Serhan Sevim, Sedat Şen et al.
Journal of Neurology
Multiple Sclerosis Research Studies
article

Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder

Belgin Koçer, Edgar Carnero-Contentti, Serhan Sevim, Sedat Şen, Tuncay Gündüz, Emine Koç, Kadriye Ağan, Güven Özkaya, Vedat Çilingir, Sanja Gluščević, Valentina Camera, Hüsnü Efendi, Murat Kürtüncü, Özden Kamışlı, Uğur Uygunoğlu, Cihat Uzunköprü, Massimiliano Calabrese, Caner Fevzi Demir, Yeşim Beckmann, Ipek Güngör-Doğan, Burcu Altunrende, Merve Bahar Ercan, Haluk Gümüş, Aksel Siva, Cavit Boz, Melih Tütüncü, Gulsen Akman-Demir, Mehmet Fatih Yetkin, Sibel Canbaz-Kabay, Damla Cetinkaya-Tezer, Adriana Casallas-Vanegas, Sena Destan Bunul, Omer Faruk Turan, Sami Omerhoca, Furkan Saridas, Serkan Demir, Ayse Altıntas, Nilufer Kale-Icen, Basak Karakurum-Yuksel, Nermin Tepe, Murat Terzi
article en

Abstract

Eculizumab demonstrated robust real-world effectiveness in reducing relapse rates and stabilizing disability, with an acceptable safety profile. Clinical outcomes may be influenced by attack phenotype, underscoring the importance of early intervention.

Journal of NeurologyVol. 273(1)
Balıkesir University (TR), Van Yüzüncü Yıl Üniversitesi (TR), University of Verona (IT), Bursa Uludağ Üni̇versi̇tesi̇ (TR), Koç University (TR), Selçuk University (TR), Universidad de La Sabana (CO), Karadeniz Technical University (TR), Başkent University (TR), Bursa Technical University (TR), Dokuz Eylül University (TR), Taksim German Hospital (TR), Ondokuz Mayıs University (TR), Izmir Kâtip Çelebi University (TR), Bezmiâlem Vakıf Üniversitesi (TR), Turkish Society of Hematology (TR), Istanbul University-Cerrahpaşa (TR), Instituto de Neurología Cognitiva (AR), Sağlık Bilimleri Üniversitesi (TR), Elazığ Eğitim ve Araştırma Hastanesi (TR), Mersin Üniversitesi (TR), Kocaeli Üniversitesi (TR), University of Montenegro (ME), Istanbul University (TR), Marmara University (TR), Erciyes University (TR), Gazi University (TR)
No poverty
Openalex Percentile: Top 95%
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.